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SUMMARY
We investigate the epidemiology of 12 Verocytotoxin-producing Escherichia coli (VTEC)
serogroups observed in a calf cohort on a Scottish beef farm. Fitting mathematical models to the
observed time-course of infections reveals that there is signiﬁcant calf-to-calf transmission of
VTEC. Our models suggest that 40% of all detected infections are from calf-to-calf transmission
and 60% from other sources. Variation in the rates at which infected animals recover from
infection by diﬀerent VTEC serogroups appears to be important. Two thirds of the observed
VTEC serogroups are lost from infected calves within 1 day of infection, while the rest persist for
more than 3 days. Our study has demonstrated that VTEC are transmissible between calves and
are typically lost from infected animals in less than 1 week. We suggest that future ﬁeld studies
may wish to adopt a tighter sampling frame in order to detect all circulating VTEC serogroups in
similar animal populations.
INTRODUCTION
Verocytotoxin-producing Escherichia coli (VTEC) are
known to cause diarrhoea in young animals and hu-
mans [1, 2]. Human diarrhoeal disease can vary in
severity from mild diarrhoea to haemorrhagic colitis
(HC) and haemolytic uraemic syndrome (HUS) [3, 4].
VTEC infections in humans often occur via contact
with infected animals, or by consuming contaminated
food and water [2, 5, 6], whereas the sources of infec-
tion in animal populations are less clear. The most
common VTEC found in human patients in the
United Kingdom is the serogroup O157 [2], while
other serogroups such as O26, O103 and O111 have
also been isolated [7]. Many VTEC serogroups, in-
cluding those mentioned above, have also being de-
tected in cattle, and it has been suggested that cattle
are a potential reservoir of infection for humans [8, 9].
Thus, it is important and necessary to establish the
sources of VTEC infections in animal populations
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and the epidemiological characteristics of VTEC
serogroups.
Recently, a ﬁeld study was carried out on a Scottish
beef farm to monitor the presence of VTEC in calves
from birth over a period of 5 months [10]. The meth-
odology and the results of this study are summarized
in [10]. In brief, faecal samples were taken from 49
calves once a week from the time of birth, and iso-
lation of VTECwas carried out by a PCR/DNA probe
hybridization method [2, 10]. In that particular study,
12 VTEC serogroups were isolated from 86 calf sam-
ples (out of a total 570 collected). Faecal samples were
also taken from dams at the beginning and the end of
the study, and 40 samples (out of a total 86 collected)
were VTEC-positive. However, no calves excreted the
same VTEC serogroup as that isolated from the dams
at birth. Among those detected as VTEC, serogroup
O26 was most frequently observed throughout the
calf population (Fig. 1).
In this paper, we construct stochastic models to
describe the epidemiology of VTEC serogroups found
in the calf cohort study described above. We assume
infections can be acquired either by transmission be-
tween calves or contact with other contaminated
sources. We aim to quantify the relative importance
of these diﬀerent sources of infection. Speciﬁcally, are
all infections observed in the calf cohort a result of
random acquisition of VTEC from the environment,
or is there calf-to-calf transmission of infection?
During our study period, diﬀerent serogroups were
present at very diﬀerent prevalences, with O26 being
the serogroup most frequently isolated. We are inter-
ested in whether these observed diﬀerences are due
to diﬀerent epidemiologies of the VTEC serogroups,
or can be explained as a consequence of chance events
in the infection and recovery processes. Within the
model framework, we ask whether the dynamics of
diﬀerent VTEC serogroups observed in this calf
cohort are governed by the same epidemiological
processes and same parameter values.
This paper is organized as follows: ﬁrst, we describe
the data used in our models and the methods used for
parameter estimation. The basic building blocks of
our stochastic models are then introduced. Models
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Fig. 1. VTEC serogroups isolated from 49 calves plotted by sampling weeks during the course of study. Each box represents a
sample taken from a particular calf (identiﬁed by the labels on the vertical axis) on a particular week (identiﬁed by the week
number on the horizontal axis). Empty boxes represent samples with no VTEC serogroups detected. Coloured boxes rep-
resent samples with VTEC serogroups detected.
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are then constructed sequentially, starting with the
simplest model with the least number of parameters.
We then present the results of our models and discuss
their implications. This paper ends with a short sum-
mary of our ﬁndings and future directions.
METHODS
Data description
The VTEC serogroups isolated from individual calves
by sampling week are summarized in Figure 1. Twelve
VTEC serogroups were observed: 85 samples with
single identiﬁed serogroups, 23 samples with unknown
identity and one sample with multiple serogroups (i.e.
0720 on week 16 in Fig. 1). For each serogroup, we
deﬁne three quantities to characterize the data. The
ﬁrst is the number of positive infections, which is
the number of samples that tested positive for a
given serogroup. For instance, this quantity for VTEC
serogroup O2 is nine positive samples. The second is
the number of animals ever infected with a serogroup :
for VTEC serogroup O2 this is eight animals. The
third is infection weeks, which is deﬁned as the number
of weeks for which at least one sample tested positive
for a given serogroup: for VTEC serogroup O2, this
is 6 weeks. Figure 2 summarizes the means, variances
and distributions of these three quantities for the 12
serogroups. Two thirds of observed VTEC sero-
groups have low numbers of positive infections, ani-
mals ever infected, and infection weeks. Serogroup
O26 is the most frequently observed serogroup with
the highest numbers of positive infections, animals
ever infected and infection weeks.
Maximum-likelihood (ML) method of parameter
estimation
We use ML methods to estimate parameter values
and their conﬁdence intervals [11, 12]. Following
these methods, the best parameter set is the one for
which a given model is most likely to produce the
observed data. Here, the observed data are the num-
bers of positive infections, the numbers of animals
ever infected and the infection weeks for each of the
12 observed serogroups. To calculate the probability
of observing the data for a given model and parameter
set, we simulate the modelN times (hereN=1000000)
to construct a probability space. We then count
the number of simulations for which we reproduce
the observed data. Once we have the probability of
observing the data, the negative log likelihood value
for a model with a particular parameter set can be
easily calculated [11] : a negative log likelihood value
is simply the product ofx1 and the logarithm of the
probability of observing the data.
Trial simulations are conducted to ascertain bio-
logically relevant areas of parameter space. We then
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Fig. 2.Distributions of (a) the number of positive infections,
(b) the number of animals ever infected and (c) the infection
weeks for VTEC serogroups observed in the data.
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systematically search through the appropriate par-
ameter space and calculate the probability of observ-
ing the data and the associated negative log likelihood
value for each parameter set. For each parameter,
the search range is chosen such that it incorporates
the lower and upper 95% conﬁdence intervals of the
best parameter value. The best parameter set is de-
ﬁned as the one with the highest probability of observ-
ing the data (i.e. the smallest negative log likelihood
value) [11].
The basics
For each VTEC serogroup, we construct a stochastic
Susceptible–Infected–Susceptible (SIS) process con-
ﬁned by the cohort structure of the calf population.
During this farm study, individual calves were born
into the cohort at diﬀerent times. Therefore, we in-
troduce calves into our models according to their
actual dates of birth. Two calves died before the
completion of the study (i.e. 0658 and 0704 in Fig. 1),
and were, therefore, removed from the model on their
dates of death. During this study we also kept a
record of the exact dates when samples were taken
from calves. Therefore, during the simulation of our
models, we take samples from individual calves ac-
cording to the actual sampling dates.
A simple stochastic SIS process is assumed to de-
scribe the infections of calves by each VTEC sero-
group. Susceptible calves (S) can acquire infection
via two diﬀerent routes. First is by direct or indirect
contact with infected calves (I) at a rate bSI, where
b is the internal transmission coeﬃcient of a VTEC
serogroup. Indirect contact here includes cases where
a susceptible calf becomes infected after an encounter
with an infectious source that was originally con-
taminated by another infected calf. Second, calves can
become infected by contact with other infectious
sources on a farm at a rate hS, where h is the external
transmission coeﬃcient. The external route of trans-
mission includes all other infectious sources not con-
sidered by the internal route. This includes infectious
dams and all contaminated objects as long as infec-
tion and contamination were not caused by infectious
calves ; otherwise they are considered as indirect trans-
mission from infectious calves. We assume an initial
condition with no infected calves and, therefore, the
very ﬁrst infection in the cohort must be from external
sources. Infected calves (I) recover at a rate cI, where
c is the recovery parameter. The infection dynamics for
a given VTEC serogroup are illustrated in Figure 3,
and can be expressed as a set of diﬀerential equations
that describe the rates of changes in the numbers of
susceptible and infected calves :
dS
dt
=xbSIxhS+cI; (1)
dI
dt
=bSI+hSxcI: (2)
To simulate stochastically our simple SIS process
based on equations (1) and (2) for a ﬁnite population,
we construct a sequence of events by adopting the
methodology in [13]. Imagine we are at the end of the
ith event, the methodology involves the determination
of waiting time s, until the occurrence of the i+1th
event and what happens in the i+1th event. Here, one
of the following can happen in the i+1th event: the
infection of one susceptible calf via the internal route
with a probability of bSiIi/(bSiIi+hSi+cIi) ; the in-
fection of one susceptible calf via the external route
with a probability of hIi/(bSiIi+hSi+cIi) ; or the
recovery of an infected calf with a probability of
cIi/(bSiIi+hSi+cIi). In those expressions, Si and Ii
are the numbers of susceptible and infected calves
at the end of ith event. If an infection occurs, then the
number of susceptible calves decreases by 1, and the
number of infected calves increases by 1; if a recovery
event occurs, then the number of infected calves de-
creases by 1, and the number of susceptible calves
increases by 1. We assume the waiting time s, from
the ith event to the i+1th event is an exponentially
distributed random variable [13]. To incorporate the
calf cohort structure into the SIS process, we simply
adjust the numbers of calves throughout according to
the observed occurrence of births and deaths.
In addition to the cohort structure and SIS pro-
cess described above, we sample from the process
S S
I
β γ
γθ I
Fig. 3. A simple SIS process : a susceptible calf (S) acquires
infection either by the internal transmission route (b) or
the external transmission route (h). An infected calf (I) can
regain susceptible status again after recovery (c).
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according to the actual sampling dates used during the
farm study. In our models, faecal samples are taken
from calves once a week during a period of 17 weeks;
infections, therefore, will not be detected if they occur
between two sampling dates. As such, it is possible
that some serogroups may not be detected within the
sampling frame even though infections do occur in the
calf cohort. We estimate how many serogroups may
have been missed by this particular sampling frame.
Homogeneous model
The homogeneous model (Hom) assumes all VTEC
serogroups have the same epidemiological parameters.
The model also assumes no interactions between dif-
ferent serogroups, and allows for multiple VTEC in-
fections in a sample. Since 12 VTEC serogroups were
observed in the data, we require 12 independent SIS
processes in the model. We estimate the best par-
ameter set and determine its conﬁdence intervals
using the ML method described above [11, 12]. For b,
the internal transmission coeﬃcient, we search in a
range from 0 to 0.02/day per calf with an increment
of 0.001/day per calf. For h, the external transmis-
sion coeﬃcient, we search in a range from 0.00025
to 0.005/day with an increment of 0.00025/day. The
range searched for c, the recovery parameter, is from
0.05 to 1/day with an increment of 0.05/day.
Heterogeneous model
All assumptions are the same as the homogenous
model except that heterogeneity is introduced in one
of the three epidemiological parameters. There are
three heterogeneous models : we refer to models with
heterogeneity in the internal transmission coeﬃcient
(b), external transmission coeﬃcient (h) and recovery
parameter (c) as models Het(b), Het(h) and Het(c)
respectively. For simplicity, we choose a binary div-
ision for each epidemiological parameter : for model
Het(b) there are two parameters for internal trans-
mission coeﬃcient, b1 and b2 ; for model Het(h) there
are two external transmission coeﬃcients, h1 and h2 ;
and similarly for model Het(c) there are two recovery
parameters, c1 and c2. For each heterogeneous model,
we deﬁne another new parameterm, which is the num-
ber of VTEC serogroups that have epidemiological
parameters with subscript 1. Like the homogeneous
model, we use the ML method [11, 12] to estimate the
best parameter sets and determine their conﬁdence
intervals. For b, the internal transmission coeﬃcient,
we search in a range from 0 to 0.02/day per calf with
an increment of 0.002/day per calf. For h, the external
transmission coeﬃcient, we search in a range from
0.0005 to 0.00165/day with an increment of 0.0005/
day. The range searched for c, the recovery parameter,
is from 0.1 to 12/day with the following increments :
for c=0.1 to 3/day, the increment is 0.1/day; for c=4
to 12/day, the increment is 1/day. A smaller increment
for lower values of c is needed because the best value
lies within the lower range (see the Results section)
and we wish to determine a more accurate estimate.
We also search the best parameter sets with diﬀerent
values of m, starting from m=0 to m=12.
RESULTS
Homogeneous model
For the homogeneous model, the best parameter value
for the internal transmission coeﬃcient (b) is 0.004/
day per calf (95% CI 0.002–0.009). This suggests that
on average, a calf encounters a given infected calf and
becomes infected once every 250 days (1/0.004). For
the external transmission coeﬃcient (h) the best ﬁt
value is 0.001/day (95% CI 0.0005–0.00325). This
implies that a given calf on average acquires a VTEC
serogroup once every 1000 days (1/0.001). For the
recovery parameter (c) the best ﬁt value is 0.2/day
(95% CI 0.15–0.5) and this suggests that the average
duration of infectiousness isy5 days (1/0.2).
To check how well the homogeneous model de-
scribes the data, we can simulate the model 10 000
times with the best parameter values. For each realiz-
ation, the means and variances of the number of
positive infections, number of animals ever infected
and infection weeks are calculated. We then plot dis-
tributions of those model means and variances and
ask where the means and variances of the observed
data are placed within the model distributions. All
observed data means and variances are all placed
within the 95% conﬁdence region in the model dis-
tributions except the variance for infection weeks
(Fig. 4a) ; the homogeneous model thus fails to ex-
plain the variation in infection weeks.
Heterogeneous models
According to the likelihood ratio test [11], for the
heterogeneous models (with ﬁve parameters) to rep-
resent a signiﬁcant improvement over the homo-
geneous model (with three parameters) at the 0.05
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level, a reduction of 3 or more in the negative log
likelihood value is required. The negative log likeli-
hood values given in Table 1 show that only the model
with heterogeneity in the recovery rate [i.e. Het(c)]
is signiﬁcantly better than the homogeneous model,
although other heterogeneous models are also im-
provements on the homogeneous model.
For model Het(c), the best parameter value for
the internal transmission coeﬃcient (b) is 0.004/day
per calf (95% CI 0.002–0.012), and the best ﬁt value
for the external transmission coeﬃcient parameter (h)
is 0.005/day (95% CI 0.002–0.0125). For the two
recovery parameters c1 and c2, the best ﬁt values are
0.3/day (95% CI 0.2–0.7) and 1.9/day (95% CI
1.10–8.0) respectively. Note that the best estimates
for the internal transmission coeﬃcient (b) for both
the homogeneous model and model Het(c) are the
same. For the external transmission coeﬃcient (h) and
the recovery parameters (c1 or c2), the estimates for
model Het(c) are much higher than the homogeneous
model. In other words, increases in the external
transmission coeﬃcient (h) are compensated by faster
recovery rates (c1 or c2). Model Het(c) suggests that
four serogroups have a lower recovery rate c1 and
eight serogroups have a much higher recovery rate c2.
Furthermore, model Het(c) is the model that best
explains the observed variance in infection weeks
(Fig. 4b).
Estimating the number of VTEC serogroups present
In our model simulations, some infected calves will
not be recorded as positive for VTEC serogroups
simply because we sample only on speciﬁc days. Thus,
for some model simulations fewer than 12 VTEC
serogroups will be detected. We can simulate models
with diﬀerent numbers of VTEC serogroups (i.e. dif-
ferent numbers of SIS processes) and calculate the
average number of serogroups observed given the
sampling frame. Our results suggest that in order to
observe an average of 12 serogroups, we have to in-
clude an average of 14 serogroups in the model.
Furthermore, if more than 17 serogroups are included
in the model, then in fewer than 5% of model simu-
lations will 12 VTEC serogroups be detected (Fig. 5).
Thus, in order to observe 12 serogroups in the data,
we estimate that 12–17 serogroups are circulating in
the calf cohort.
Sources of infection
With 14 serogroups (as this gives an average of 12
observed serogroups), we simulate 10 000 times the
homogeneous model and the model with heterogen-
eity in recovery rate [i.e. model Het(c)] using the
ML parameter estimates. For each realization, we
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Fig. 4. (a) Distribution of model variance for infection
weeks for the homogeneous model. The bold line indicates
where the data variance is placed within the model distri-
bution. The dashed lines are the 95% conﬁdence limits. (b)
Distribution of model variance for infection weeks for
model Het(c). The bold line indicates where the data
variance is placed within the model distribution. The dashed
lines are the 95% conﬁdence limits.
Table 1. Negative log likelihood values for all models
Model
Negative log
likelihood values
Diﬀerence to the
homogeneous model
Hom 24.49 0
Het(b) 23.64 0.85
Het(h) 21.76 2.73
Het(c) 19.87 4.62
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determine the source of infection for each infected
sample. For the homogeneous model, our result sug-
gests 70% (95% CI 48–83) of all infections arise
through calf-to-calf transmission (both direct and
indirect), whereas this ﬁgure decreases to 40% (95%
CI 19–55) for model Het(c). Thus, according to the
homogeneous model, only 30% of infections are from
external sources. However, this ﬁgure increases to
60% for model Het(c). This rise in the proportion of
infections from external sources is expected since the
value for the external transmission coeﬃcient (h) for
model Het(c) is ﬁve times larger than that for the
homogeneous model.
We can also track each infected sample and deter-
mine the frequency of single and consecutive infec-
tions. For consecutive infections, we then determine
whether the infection following the initial infection
is a consequence of persistence or re-infection (i.e. a
calf recovering and then acquiring infection again the
following week). The number of observed single and
consecutive infections in the data (there were 86 posi-
tive samples, among which 68 were single infections
and 18 were involved in double consecutive infections)
is predicted well by model Het(c) (Table 2; x2=3.69,
D.F.=3, P=0.298). Whilst the 95% conﬁdence inter-
vals do include zero samples with triple consecutive
infections (Table 2), this is only true for 31% of the
model simulations. No quadruple consecutive infec-
tions were observed in the data (Table 2) nor in 85%
of the model simulations. Only 15% of the model
simulations showed the occurrence of quadruple
consecutive infections. Furthermore, the model pre-
dicts that among those double consecutive infections
observed in the data, 88% of them are the result of
persistence of VTEC serogroups within the calves,
whereas only 12% are the result of re-infections.
Estimating the number of samples with multiple
infections
We have assumed independent SIS processes for all
VTEC serogroups in all models ; therefore, more than
one serogroup may be present in any one calf faecal
sample. To estimate the expected number of samples
with multiple infections, we can run simulations with
14 serogroups (because this gives an average of 12
observed serogroups) 10 000 times, and for each re-
alization we determined the number of serogroups per
sample. Of 570 samples collected, the data shows 484
samples with no infections, 85 samples with a single
serogroup and only one sample with two serogroups
(Table 3). Model Het(c) predicts the observed data
reasonably well (Table 3; x2=5.22, D.F.=3, P=
0.156). On average, the model predicts 484 samples
with no infections, 79.2 samples with a single sero-
group and 6.56 samples with double infections. The
95% conﬁdence intervals do include only one sample
with double infections (Table 3) ; however, only 12%
of the model simulations have one sample with double
Table 2. Numbers of samples out of a total of 86 involving single, double,
triple and quadruple consecutive infections
Data Model
Out of 86 positive samples
Single infection 68 (80%) 65.6 (76.3%, 63–93)
Double consecutive infection 18 (20.9%) 16.3 (18.9%, 5–31)
Triple consecutive infection 0 (0%) 3.41 (3.96%, 0–12)
Quadruple consecutive infection 0 (0%) 0.006 (0.007%, 0–6)
The values within parentheses are the percentages of samples and their 95%
conﬁdence intervals.
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infections. Samples with three or more serogroups
were not observed in the data (Table 3) or in 75% of
the model simulations. Only 25% of the model simu-
lations have samples infected with three serogroups.
DISCUSSION
A previous analysis of this calf cohort [10] has shown
that VTEC serogroups isolated from calves were dif-
ferent to those isolated from their dam at birth; it has,
therefore, been suggested that calves might acquire
their VTEC infections from environmental sources
[10]. Here, we have assumed that calves can acquire
infections either from other infected calves (directly
or indirectly) or from other sources (this also includes
an infected dam). Our estimates show the transmission
coeﬃcient to be signiﬁcantly greater than zero. There-
fore, the model results suggest there is calf-to-calf
VTEC transmission within the calf cohort. Moreover,
our results reveal that a substantial proportion of in-
fections arises via this route [70% of all infections are
from calf-to-calf transmission for the homogeneous
model and 40% for model Het(c)].
Heterogeneity can be introduced into the homo-
geneous model in many diﬀerent ways: one can have
heterogeneity in one, two or all epidemiological par-
ameters in various combinations; or one can go
beyond the binary division and have 3, 4, 5 or more
diﬀerent values for each epidemiological parameter.
To determine fully the diﬀerences between diﬀerent
VTEC serogroups in terms of epidemiological charac-
teristics will require a complete exploration of all poss-
ible heterogeneous models (and ultimately estimation
of parameter values for each serogroup). Therefore,
the conclusion we draw from our simpler hetero-
geneous models is conservative. We have found that
there is, at least, a diﬀerence between those observed
VTEC serogroups. For this particular dataset, model
Het(c) suggests that this diﬀerence is in the rate at
which VTEC serogroups are lost from calves. In par-
ticular, we estimate four serogroups to have low re-
covery rates and eight to have much higher recovery
rates. A higher recovery rate can reduce the total num-
ber of infections observed and as a result reduce the
number of animals ever infected and infection weeks.
This division of two classes of VTEC serogroups is
observed in the data where eight serogroups have
small numbers of total infections and animals ever
infected, as well as very short infection weeks (Fig. 2).
Recovery rate also has an impact on how often we see
consecutive infections. The data shows that there are
nine occurrences of double consecutive infections (i.e.
18 samples involved in double consecutive infections),
and our model suggest that eight of these occurrences
(88%) are the result of persistence of VTEC sero-
groups within calves rather than re-infection.
Our results also suggest that calves are typically
infected for less than a week, with estimates for
recovery periods ranging from 5 days for the homo-
geneous model, to as little as <1 day for the hetero-
geneous model. It is possible, therefore, that the
weekly sampling adopted in practice failed to detect
some additional circulating serogroups. Our results
suggest that in order to observe an average of 12 sero-
groups, there may be on average 14 serogroups cir-
culating in the calf cohort. A tighter sampling frame
would be required to observe all the serogroups cir-
culating in this particular calf cohort. Imperfect sen-
sitivity of the PCR/DNA probe hybridization method
might also result in missing serogroups [2]. To test
this, we incorporated a sensitivity parameter into our
homogeneous model. We deﬁne sensitivity as the
probability of a sample being tested positive if it is
infected with a serogroup. We found that the par-
ameter values for the homogeneous model are robust
across a wide range of sensitivities (from 0.2 to 1), and
that the homogenous model with sensitivity is not
statistically a signiﬁcantly better model. Therefore, we
concluded that sensitivity is not an important factor
in explaining the data.
Although the 95% conﬁdence intervals for the
number of samples infected with two serogroups
do include one sample (Table 3), 88% of the model
simulations show that there are more than one sample
with double infections (on average, 6.56 samples are
expected, see Table 3). Thus, the model clearly over-
estimates the number of samples with double infec-
tions ; or there should be more than one sample with
Table 3. Numbers of samples infected with 0, 1, 2
and 3 VTEC serogroups
Out of 570 samples
Number of
serogroups Data Model
0 484 (84.9%) 484 (84.9%, 75–94)
1 85 (14.9%) 79.2 (13.9%, 6–22)
2 1 (0.175%) 6.56 (1.15%, 0–3)
3 0 (0%) 0.0969 (0.02%, 0–0)
The values within parentheses are the percentages of sam-
ples and their 95% conﬁdence intervals.
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double infections in the data. There are several po-
tential explanations to account for this. First, the as-
sumption of independent infections for all serogroups
might be inappropriate in our models. Experiments
in microbiology are thus required to investigate the
possibility of interactions between diﬀerent VTEC
serogroups. Second, the detection/isolation method
for VTEC serogroup may not be suﬃciently sensitive
to detect more than one serogroup per sample. For
the method to detect a particular VTEC serogroup,
the number of organisms in each faecal sample must
be above a detection threshold [10, 14]. Furthermore,
Pearce et al. [15] used immunomagnetic separation
(IMS) to detect VTEC in the same calf cohort and
detected serogroup O145, which was not isolated by
the PCR/DNA probe hybridization method used
by Shaw et al. [10]. Therefore, it is possible that the
number of serogroups observed per sample (or even
across the whole calf cohort) might be limited by the
detection method used. Finally, it might simply be
due to VTEC serogroups in the material taken from
each faecal sample for detection not being fully rep-
resentative of those in individual calves : this is a
potential worry in our study since only a small amount
(i.e. 1 g) was taken from each faecal sample for VTEC
detection.
CONCLUSION
In this paper, we have modelled the epidemiology of
12 VTEC serogroups observed in a calf cohort on a
Scottish beef farm. Our models suggest there is calf-
to-calf transmission of VTEC serogroups within the
calf cohort (the transmission coeﬃcient of VTEC
within the calf population is signiﬁcantly greater than
zero), but a substantial proportion of transmission is
from other sources (60% of all infections). Our ﬁnd-
ings suggest that some VTEC serogroups have a very
short duration of infection of <1 day, while there is
evidence that some VTEC serogroups have a longer
duration of infection (3–5 days). We also demon-
strated there is no good evidence that internal and ex-
ternal transmission rates vary among diﬀerent VTEC
serogroups. Our model predicts that of all consecutive
infections that were observed in the data, the majority
(88%) are from the persistence of VTEC serogroups
within infected calves. Our ﬁndings also suggest that
some VTEC serogroups are transient in this calf co-
hort with calves recovering within a day of infection,
and therefore a tighter sampling frame may be re-
quired to detect all circulating serogroups in future
studies. The use of complementary detection methods
in future studies could also help to ensure that the
number of serogroups observed is not limited by the
use of a particular isolation method. We are aware
that the data used were from a particular farm, which
may not be a truly representative of all the farms in
the United Kingdom. We plan to apply this method-
ology to other datasets and test the robustness of our
conclusions.
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